Literature DB >> 27376810

Role of axl in preeclamptic EPCs functions.

Ying Hu1, Xiao-Ping Liu1, Xiao-Xia Liu1, Yan-Fang Zheng1, Wei-Fang Liu1, Ming-Lian Luo1, Hui Gao1, Ying Zhao1, Li Zou2.   

Abstract

Axl encodes the tyrosine-protein kinase receptor, participating in the proliferation and migration of many cells. This study examined the role of Axl in functions of endothelial progenitor cells (EPCs). Axl was detected by RT-PCR and Western blotting in both placentas and EPCs from normal pregnancy and preeclampsia patients. The Axl inhibitor, BMS777-607, was used to inhibit the Axl signalling pathway in EPCs. Cell proliferation, differentiation, migration and adhesion were measured by CCK-8 assay, cell differentiation assay, Transwell assay, and cell adhesion assay, respectively. Results showed the expression levels of Axl mRNA and protein were significantly higher in both placentas and EPCs from preeclampsia patients than from normal pregnancy (P<0.05). After treatment with BMS777-607, proliferation, differentiation, migration and adhesion capability of EPCs were all significantly decreased. Our study suggests Axl may play a role in the function of EPCs, thereby involving in the pathogenesis of preeclampsia.

Entities:  

Keywords:  Axl; endothelial progenitor cells; preeclampsia

Mesh:

Substances:

Year:  2016        PMID: 27376810     DOI: 10.1007/s11596-016-1598-3

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  36 in total

Review 1.  Placental origins of preeclampsia: challenging the current hypothesis.

Authors:  Berthold Huppertz
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

2.  Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood.

Authors:  C Ekman; J Stenhoff; B Dahlbäck
Journal:  J Thromb Haemost       Date:  2010-01-17       Impact factor: 5.824

3.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

Review 4.  Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Expert Opin Ther Targets       Date:  2010-10       Impact factor: 6.902

5.  Multiple roles for the receptor tyrosine kinase axl in tumor formation.

Authors:  Sacha J Holland; Mark J Powell; Christian Franci; Emily W Chan; Annabelle M Friera; Robert E Atchison; John McLaughlin; Susan E Swift; Erlina S Pali; George Yam; Stephen Wong; Joe Lasaga; Mary R Shen; Simon Yu; Weiduan Xu; Yasumichi Hitoshi; Jakob Bogenberger; Jacques E Nör; Donald G Payan; James B Lorens
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

6.  Expression of the proto-oncogene Axl in renal cell carcinoma.

Authors:  Benjamin I Chung; S Bruce Malkowicz; Trang B Nguyen; John A Libertino; Terence W McGarvey
Journal:  DNA Cell Biol       Date:  2003-08       Impact factor: 3.311

7.  Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells.

Authors:  Ines Hasanbasic; Jessica Cuerquis; Brian Varnum; Mark D Blostein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-06       Impact factor: 4.733

8.  MicroRNA-126 regulates EPCs function: implications for a role of miR-126 in preeclampsia.

Authors:  Ting Yan; Yan Liu; Kai Cui; Bin Hu; Fang Wang; Li Zou
Journal:  J Cell Biochem       Date:  2013-09       Impact factor: 4.429

9.  Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies.

Authors:  Jin Hur; Han-Mo Yang; Chang-Hwan Yoon; Choon-Soo Lee; Kyung-Woo Park; Ji-Hyun Kim; Tae-Youn Kim; Ju-Young Kim; Hyun-Jae Kang; In-Ho Chae; Byung-Hee Oh; Young-Bae Park; Hyo-Soo Kim
Journal:  Circulation       Date:  2007-10-01       Impact factor: 29.690

10.  Pregnancy-induced hypertension is accompanied by decreased number of circulating endothelial cells and circulating endothelial progenitor cells.

Authors:  Jerzy Heimrath; Maria Paprocka; Andrzej Czekanski; Agata Ledwozyw; Aneta Kantor; Danuta Dus
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-02-23       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.